145 related articles for article (PubMed ID: 33327254)
1. Association between CYP2A13 polymorphisms and lung cancer: A protocol for systematic review and meta-analysis.
Ma L; Jin G; Yang Y; Pang Y; Wang W; Zhang H; Liu J; Wu P; Wang Z; Wang K; Chang R; Li J; Zhu Z
Medicine (Baltimore); 2020 Dec; 99(50):e23289. PubMed ID: 33327254
[TBL] [Abstract][Full Text] [Related]
2. Substantial reduction in risk of lung adenocarcinoma associated with genetic polymorphism in CYP2A13, the most active cytochrome P450 for the metabolic activation of tobacco-specific carcinogen NNK.
Wang H; Tan W; Hao B; Miao X; Zhou G; He F; Lin D
Cancer Res; 2003 Nov; 63(22):8057-61. PubMed ID: 14633739
[TBL] [Abstract][Full Text] [Related]
3. Association of folate metabolism-related genetic polymorphisms with susceptibility to breast cancer: A protocol for a systematic review and meta-analysis.
Wang C; Tong CM; Zhang Y; Chen GX; Xiong F; Wang J
Medicine (Baltimore); 2021 Aug; 100(32):e26926. PubMed ID: 34397937
[TBL] [Abstract][Full Text] [Related]
4. Pulmonary expression of CYP2A13 and ABCB1 is regulated by FOXA2, and their genetic interaction is associated with lung cancer.
Xiang C; Wang J; Kou X; Chen X; Qin Z; Jiang Y; Sun C; Xu J; Tan W; Jin L; Lin D; He F; Wang H
FASEB J; 2015 May; 29(5):1986-98. PubMed ID: 25667220
[TBL] [Abstract][Full Text] [Related]
5. Cytochrome P450 2A6 deletion polymorphism and risk of lung cancer: a meta-analysis.
Liu ZB; Shu J; Wang LP; Jin C; Lou ZX
Mol Biol Rep; 2013 Sep; 40(9):5255-9. PubMed ID: 23733493
[TBL] [Abstract][Full Text] [Related]
6. Relationship between thrombomodulin gene polymorphism and susceptibility to venous thromboembolism: A protocol for systematic review and meta-analysis.
Wei M; Xue X; Pan Y; Wu Y
Medicine (Baltimore); 2021 Mar; 100(11):e25001. PubMed ID: 33725974
[TBL] [Abstract][Full Text] [Related]
7. Association of CYP2A6*4 with susceptibility of lung cancer: a meta-analysis.
Wang L
PLoS One; 2013; 8(4):e59556. PubMed ID: 23585826
[TBL] [Abstract][Full Text] [Related]
8. Association between cancer risk and drug-metabolizing enzyme gene (CYP2A6, CYP2A13, CYP4B1, SULT1A1, GSTM1, and GSTT1) polymorphisms in cases of lung cancer in Japan.
Tamaki Y; Arai T; Sugimura H; Sasaki T; Honda M; Muroi Y; Matsubara Y; Kanno S; Ishikawa M; Hirasawa N; Hiratsuka M
Drug Metab Pharmacokinet; 2011; 26(5):516-22. PubMed ID: 21791872
[TBL] [Abstract][Full Text] [Related]
9. Genetic and Enzymatic Characteristics of CYP2A13 in Relation to Lung Damage.
Vrzal R
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830188
[TBL] [Abstract][Full Text] [Related]
10. Genetic polymorphism of the human cytochrome CYP2A13 in a French population: implication in lung cancer susceptibility.
Cauffiez C; Lo-Guidice JM; Quaranta S; Allorge D; Chevalier D; Cenée S; Hamdan R; Lhermitte M; Lafitte JJ; Libersa C; Colombel JF; Stücker I; Broly F
Biochem Biophys Res Commun; 2004 Apr; 317(2):662-9. PubMed ID: 15063809
[TBL] [Abstract][Full Text] [Related]
11. The missense genetic polymorphisms of human CYP2A13: functional significance in carcinogen activation and identification of a null allelic variant.
Wang SL; He XY; Shen J; Wang JS; Hong JY
Toxicol Sci; 2006 Nov; 94(1):38-45. PubMed ID: 16917071
[TBL] [Abstract][Full Text] [Related]
12. Relationship between long non-coding RNA polymorphism and the risk of coronary artery disease: A protocol for systematic review and meta-analysis.
Wang B; Su Z; Wan L; He T
Medicine (Baltimore); 2021 Mar; 100(12):e25146. PubMed ID: 33761682
[TBL] [Abstract][Full Text] [Related]
13. Association between NEAT1 polymorphism and the risk of lung cancer: A protocol for systematic review and meta-analysis.
Hu Z; Chen J; Meng P; Li M
Medicine (Baltimore); 2021 Apr; 100(16):e25478. PubMed ID: 33879681
[TBL] [Abstract][Full Text] [Related]
14. Association between cytochrome P450 2C9 gene polymorphisms and colorectal cancer susceptibility: evidence from 16 case-control studies.
Wang H; Ren L; He Y; Wei Y; Chen Z; Yang W; Fu Y; Xu X; Fu W; Hu G; Lou W
Tumour Biol; 2014 May; 35(5):4317-22. PubMed ID: 24414392
[TBL] [Abstract][Full Text] [Related]
15. Association of cytochrome P450 2C19 polymorphisms with coronary heart disease risk: A protocol for systematic review and meta analysis.
Yang Y; Zhang Y; Ren M; Wang Y; Cairang Z; Lin R; Sun H; Liu J
Medicine (Baltimore); 2020 Dec; 99(50):e23652. PubMed ID: 33327349
[TBL] [Abstract][Full Text] [Related]
16. Association of NAT2, GSTM1, GSTT1, CYP2A6, and CYP2A13 gene polymorphisms with susceptibility and clinicopathologic characteristics of bladder cancer in Central China.
Song DK; Xing DL; Zhang LR; Li ZX; Liu J; Qiao BP
Cancer Detect Prev; 2009; 32(5-6):416-23. PubMed ID: 19303722
[TBL] [Abstract][Full Text] [Related]
17. CYP2A13 Genetic Polymorphisms in Relation to the Risk of Bladder Cancer in Japanese Smokers.
Kumondai M; Hosono H; Orikasa K; Arai Y; Arai T; Sugimura H; Ozono S; Sugiyama T; Takayama T; Sasaki T; Hirasawa N; Hiratsuka M
Biol Pharm Bull; 2016; 39(10):1683-1686. PubMed ID: 27725446
[TBL] [Abstract][Full Text] [Related]
18. Functional polymorphisms in the CYP2C19 gene contribute to digestive system cancer risk: evidence from 11,042 subjects.
Zhou B; Song Z; Qian M; Li L; Gong J; Zou S
PLoS One; 2013; 8(7):e66865. PubMed ID: 23874401
[TBL] [Abstract][Full Text] [Related]
19. The association between interleukin-8 gene-251 A/T polymorphism and sepsis: A protocol for systematic review and meta analysis.
Zhao S; Gong J; Yin S; Li X; Zhao S; Mou T; Luo S
Medicine (Baltimore); 2021 Apr; 100(15):e25483. PubMed ID: 33847655
[TBL] [Abstract][Full Text] [Related]
20. Novel single nucleotide polymorphism of the CYP2A13 gene in Japanese individuals.
Tamaki Y; Honda M; Muroi Y; Arai T; Sugimura H; Matsubara Y; Kanno S; Ishikawa M; Hirasawa N; Hiratsuka M
Drug Metab Pharmacokinet; 2011; 26(5):544-7. PubMed ID: 21606606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
